REGISTERED
on 18 Jun 2024
Last Applicant/ Owned by
141 PRESIDENT KENNEDY AVE., SUITE SB-565
MONTREAL, QUEBEC
CA
H2X3Y7
Serial Number
90112472 filed on 13th Aug 2020
Registration Number
7422358 registered on 18th Jun 2024
Correspondent Address
Keith Toms, Esq.
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
CELLCARTA
Scientific research and development; Medical research and development; Product research and development; Biochemical research and development; Pharmaceutical research and development services; Biomedical research and development services; Design and development of biochemical, pharmaceutical, and medical assays; Scientific and pharmaceutical research in the field of biomarker discovery; Scientific Read More
Classification Information
Class [045]
Personal & Legal & Social Services
Regulatory compliance consulting in the fields of pharmaceuticals and clinical diagnostics; Advice and consultancy on food, drug, and medical device regulatory matters; regulatory compliance consulting in the field of obtaining government authorization to market pharmaceuticals and medical device
First Use Date in General
28th Feb 2021
First Use Date in Commerce
28th Feb 2021
Class [044]
Medical, Beauty & Agricultural Services
Genetic testing for medical purposes; Consulting services in the fields of diagnostic medical testing; Medical testing for diagnostic or treatment purposes; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; providing medical information and advice in the fields of pathology, pharmacology, and immunology; collection, organization, analysis, and reporting of medical data in connection with clinical and non-clinical trials and studies on pharmaceuticals and medical devices; immune monitoring, and genetic profiling for medical and diagnostic purposes
First Use Date in General
28th Feb 2021
First Use Date in Commerce
28th Feb 2021
Class [042]
Computer & Software Services & Scientific Services
Scientific research and development; Medical research and development; Product research and development; Biochemical research and development; Pharmaceutical research and development services; Biomedical research and development services; Design and development of biochemical, pharmaceutical, and medical assays; Scientific and pharmaceutical research in the field of biomarker discovery; Scientific research and development in the fields of bioinformatics, biomarkers, genomics, proteomics, genotyping, pathology, histopathology; immune monitoring, and genetic profiling for research and development purposes; scientific research and development in the field of mass cytometry, cellular analysis, cell sorting, pathway phenotyping, and molecular surface profiling; custom design and development of chemical reagents and biochemical assays; medical laboratory services in the field of pathology; providing laboratory testing services in the fields of bioinformatics, biomarkers, genomics, proteomics, genotyping, pathology, histopathology; Conducting clinical trials for others; Conducting clinical trials for others in the fields of pharmaceutical, medical, and scientific research; Consulting services for others in the field of design, planning, and implementation project management of clinical trials; Conducting research and clinical trials for others in the fields of oncology, infectious diseases, autoimmune disorders, and allergies; Consulting services in the field of clinical trial research; Providing medical and scientific research information in the field of clinical trials; Research and development in the pharmaceutical and biotechnology fields; Laboratory research services relating to pharmaceuticals; Software as a service (SAAS) services featuring software for informatics, bioinformatics; software as a service (SAAS) services featuring software for clinical trial data acquisition, validation, and analysis; Software as a service (SAAS) services featuring software for cellular analysis, cell sorting, pathway phenotyping, and molecular surface profiling; Software as a service (SAAS) services featuring software for cell cytometry; Software as a service (SAAS) services featuring software for managing information related to clinical trials
First Use Date in General
28th Feb 2021
First Use Date in Commerce
28th Feb 2021
Mark Details
Serial Number
No 90112472
Mark Type
No Service Mark
Attorney Docket Number
No 122623-90201
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 18th Jun 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 18th Jun 2024 | REGISTERED-PRINCIPAL REGISTER |
| 13th May 2024 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 13th May 2024 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 19th Mar 2024 | STATEMENT OF USE PROCESSING COMPLETE |
| 18th Mar 2024 | TEAS STATEMENT OF USE RECEIVED |
| 18th Mar 2024 | USE AMENDMENT FILED |
| 20th Sep 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 19th Sep 2023 | SOU EXTENSION 5 GRANTED |
| 19th Sep 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |